PE20001552A1 - Uso de agonistas ep1 selectivos que no ocurren naturalmente para aumentar el volumen oseo - Google Patents
Uso de agonistas ep1 selectivos que no ocurren naturalmente para aumentar el volumen oseoInfo
- Publication number
- PE20001552A1 PE20001552A1 PE2000000184A PE0001842000A PE20001552A1 PE 20001552 A1 PE20001552 A1 PE 20001552A1 PE 2000000184 A PE2000000184 A PE 2000000184A PE 0001842000 A PE0001842000 A PE 0001842000A PE 20001552 A1 PE20001552 A1 PE 20001552A1
- Authority
- PE
- Peru
- Prior art keywords
- cr5r5
- prostaglandin
- osteoporosis
- alkyl
- prostanoid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12306399P | 1999-03-05 | 1999-03-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20001552A1 true PE20001552A1 (es) | 2001-01-30 |
Family
ID=22406507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000000184A PE20001552A1 (es) | 1999-03-05 | 2000-03-03 | Uso de agonistas ep1 selectivos que no ocurren naturalmente para aumentar el volumen oseo |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1158969A2 (ja) |
JP (1) | JP2002538105A (ja) |
AU (1) | AU3711900A (ja) |
CA (1) | CA2366755A1 (ja) |
CO (1) | CO5150205A1 (ja) |
IL (1) | IL145128A0 (ja) |
NO (1) | NO20014192L (ja) |
NZ (1) | NZ513828A (ja) |
PE (1) | PE20001552A1 (ja) |
WO (1) | WO2000051585A2 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006118173A1 (ja) | 2005-04-28 | 2006-11-09 | Ono Pharmaceutical Co., Ltd. | 経皮吸収製剤 |
EP2085088A4 (en) | 2006-10-26 | 2012-08-29 | Ono Pharmaceutical Co | ADHESIVE PREPARATION |
US20110038884A1 (en) | 2008-04-28 | 2011-02-17 | National University Co., Hamamatsu Univer. School Of Medicine | Immunopotentiating agent comprising ep1 agonist |
WO2011109729A2 (en) * | 2010-03-05 | 2011-09-09 | University Of Rochester | Ep1 inhibition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3982016A (en) * | 1975-08-06 | 1976-09-21 | Pfizer Inc. | Bone deposition by 16-aryl-13,14-dihydro-PGE2 p-biphenyl esters |
US4621100A (en) * | 1981-09-25 | 1986-11-04 | The Upjohn Company | Treatment of osteoporosis with prostaglandins |
US4812304A (en) * | 1984-12-21 | 1989-03-14 | The Procter & Gamble Company | Treatment of osteoporosis |
AU2146592A (en) * | 1991-05-29 | 1993-01-08 | Sepracor, Inc. | Combination of nsaids and prostaglandins and uses therefor |
WO1999012551A1 (en) * | 1997-09-09 | 1999-03-18 | The Procter & Gamble Company | Method of increasing bone volume using non-naturally-occurring fp selective agonists |
JP2002527400A (ja) * | 1998-10-15 | 2002-08-27 | メルク エンド カムパニー インコーポレーテッド | 骨形成刺激方法 |
WO2000051616A1 (en) * | 1999-03-05 | 2000-09-08 | The Procter & Gamble Company | Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives |
-
2000
- 2000-03-01 JP JP2000602053A patent/JP2002538105A/ja not_active Withdrawn
- 2000-03-01 WO PCT/US2000/005196 patent/WO2000051585A2/en not_active Application Discontinuation
- 2000-03-01 CA CA002366755A patent/CA2366755A1/en not_active Abandoned
- 2000-03-01 NZ NZ513828A patent/NZ513828A/xx not_active Application Discontinuation
- 2000-03-01 AU AU37119/00A patent/AU3711900A/en not_active Abandoned
- 2000-03-01 EP EP00915937A patent/EP1158969A2/en not_active Withdrawn
- 2000-03-01 IL IL14512800A patent/IL145128A0/xx unknown
- 2000-03-03 PE PE2000000184A patent/PE20001552A1/es not_active Application Discontinuation
- 2000-03-06 CO CO00016009A patent/CO5150205A1/es unknown
-
2001
- 2001-08-29 NO NO20014192A patent/NO20014192L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20014192D0 (no) | 2001-08-29 |
EP1158969A2 (en) | 2001-12-05 |
JP2002538105A (ja) | 2002-11-12 |
CA2366755A1 (en) | 2000-09-08 |
NO20014192L (no) | 2001-11-05 |
IL145128A0 (en) | 2002-06-30 |
WO2000051585A3 (en) | 2001-01-25 |
CO5150205A1 (es) | 2002-04-29 |
AU3711900A (en) | 2000-09-21 |
WO2000051585A2 (en) | 2000-09-08 |
NZ513828A (en) | 2001-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS39604A (en) | Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators | |
NZ525700A (en) | Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor | |
PE20020637A1 (es) | Derivados de 5-oxo-pirrolidina como agonistas de prostaglandinas | |
PE20010817A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
TR200003383T2 (tr) | HIV ve diğer virüs enfeksiyonlarının tedavisine yönelik bileşimler. | |
PE20080716A1 (es) | Coterapia constituida por un derivado de heterociclosulfamida benzofusionado y uno o varios agentes anticonvulsivantes y/o antilepticos | |
CO5040216A1 (es) | Agonistas de adenosina a 1, proceso para su preparacion y composiciones farmaceuticas que los contienen | |
HK1035724A1 (en) | Compounds as selective agonists at alpha 2B or 2B/2C adrenergic receptors. | |
EA200600188A1 (ru) | Производные пиримидин-2,4-диона и их применение в качестве антагонистов рецепторов гонадолиберина | |
MA30652B1 (fr) | Composes organiques | |
CO5210903A1 (es) | Composiciones novedosas de mezcla de aceite | |
AP2001002307A0 (en) | B3 adrenergic receptor agonists and uses thereof. | |
AP2001002357A0 (en) | EP4 receptor selective agonists in the treatment of osteoporosis. | |
PE20051054A1 (es) | Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento | |
NZ509239A (en) | 2-(4-(N-salicyloyl)aminophenyl)propionic acid useful as a carrier in compositions for delivering active agents | |
RS51249B (sr) | Upotreba derivata sulfonamida sa benzo-fuzionisanim heterociklom za tretman bola | |
EP1445258A4 (en) | ACTIVATOR OF THE PEROXISOMPROLIFERATOR-ACTIVATED RECEPTOR DELTA | |
PL1646389T3 (pl) | Pochodne pirymidyno-2,4-dionu jako antagoniści receptora hormonu uwalniającego gonadotropiny | |
AR070336A1 (es) | Derivado tiazol y su uso como inhibidor de vap-1 | |
PL367696A1 (en) | 2 pyrrolidone derivatives as prostanoid agonists | |
PE20020844A1 (es) | Derivados de imidazolilo como inhibidores del factor de liberacion de la corticotropina | |
PE119099A1 (es) | Metodo para aumentar el volumen oseo utilizando agonistas selectivos fp que no ocurren naturalmente | |
PE71599A1 (es) | Inhibidores de proteasas | |
MX2007005199A (es) | Indolizinas sustituidas y derivados como agentes del sistema nervioso central. | |
BR9307580A (pt) | Compostos processo para a preparação dos mesmos composições farmacêuticas uso de um composto e processo de tratamento de um mamífero que inclui o ser humano |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AE | Restoration of lapsed or forfeited application | ||
FC | Refusal |